483 Baxter Pharmaceutical Solutions Mar 2011

483 Baxter Pharmaceutical Solutions Mar 2011

Jeffrey Meng FDA, Emily Orban FDA$119.00 - Available Now

FDA investigators audited the Baxter Pharmaceutical Solutions - Bloomington, IN, United States facility and issued inspectional observations (via FDA 483) on 25 Mar 2011.

Product details

  • Category: Human Drugs
  • Inspection end: 25 Mar 2011
  • Location: Bloomington, United States
  • FEI: 1000115571
Add To Cart